Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
NCT01115426Phase 4Completed
- Sponsor
- University of Magna Graecia
- Start
- Jan 1997
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ramipril in immunoglobulin A nephropathy (IgAN) and mesangioproliferative glomerulonephritis (MesPGN), sponsored by University of Magna Graecia. Primary endpoint: Renal function and proteinuria at 1 year. Started Jan 1997; status: completed.
02
Drugs
ramipril
03
Conditions
immunoglobulin A nephropathy (IgAN)mesangioproliferative glomerulonephritis (MesPGN)
Beyond the preview
Go deeper on NCT01115426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01115426.